Stocks and Investing
by (remove) : Steve Chesney
RSSJSONXMLCSV
Stocks and Investing
by (remove) : Steve Chesney
RSSJSONXMLCSV
Thu, June 27, 2024
Tue, February 6, 2024
Tue, August 8, 2023
Fri, July 28, 2023
Wed, June 14, 2023
Fri, May 26, 2023
Wed, April 26, 2023
Fri, February 10, 2023
Fri, February 3, 2023
Thu, December 1, 2022
Thu, November 10, 2022
Mon, October 31, 2022
Thu, October 27, 2022
Wed, October 26, 2022
Mon, September 12, 2022
Tue, August 9, 2022
Mon, August 1, 2022
Thu, July 28, 2022
Wed, April 28, 2021
Mon, November 9, 2020
Tue, June 23, 2020
Wed, August 14, 2019
Thu, March 21, 2019
Wed, August 8, 2018
Mon, February 5, 2018
Fri, December 18, 2015

Steve Chesney Initiated (VRTX) at Strong Buy and Held Target at $545 on, Jun 27th, 2024


Published on 2024-10-28 12:09:03 - WOPRAI, Steve Chesney
  Print publication without navigation


Steve Chesney of Redburn Atlantic, Initiated "Vertex Pharmaceuticals Incorporated" (VRTX) at Strong Buy and Held Target at $545 on, Jun 27th, 2024.

Steve has made no other calls on VRTX in the last 4 months.



There are 12 other peers that have a rating on VRTX. Out of the 12 peers that are also analyzing VRTX, 2 agree with Steve's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Brian Abrahams of "RBC Capital" Maintained at Hold with Decreased Target to $421 on, Tuesday, June 11th, 2024
  • Joseph Stringer of "Needham" Reiterated at Hold on, Tuesday, May 7th, 2024


These are the ratings of the 10 analyists that currently disagree with Steve


  • Mohit Bansal of "Wells Fargo" Maintained at Buy with Increased Target to $555 on, Monday, June 24th, 2024
  • Jasper Hellweg of "Argus Research" Maintained at Strong Buy with Increased Target to $550 on, Monday, June 17th, 2024
  • Evan Seigerman of "BMO Capital" Maintained at Buy with Increased Target to $500 on, Friday, May 31st, 2024
  • Christopher Raymond of "Piper Sandler" Maintained at Buy with Increased Target to $456 on, Tuesday, May 7th, 2024
  • Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $462 on, Tuesday, May 7th, 2024
  • Debjit Chattopadhyay of "Guggenheim" Maintained at Strong Buy with Increased Target to $450 on, Thursday, April 18th, 2024
  • Colin Bristow of "UBS" Maintained at Strong Buy with Decreased Target to $466 on, Wednesday, April 17th, 2024
  • Hartaj Singh of "Oppenheimer" Maintained at Buy and Held Target at $500 on, Monday, April 15th, 2024
  • Whitney Ijem of "Canaccord Genuity" Maintained at Strong Sell and Held Target at $371 on, Friday, April 12th, 2024
  • Liisa Bayko of "Evercore ISI Group" Upgraded from Hold to Buy and Held Target at $438 on, Thursday, April 11th, 2024
Contributing Sources